Total Payments
$4,551
2024 Payments
$1,912
Companies
23
Transactions
220
Medicare Patients
167
Medicare Billing
$25,704
Payment Breakdown by Category
Food & Beverage$4,524 (99.4%)
Education$27.27 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,524 | 219 | 99.4% |
| Education | $27.27 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $718.10 | 44 | $0 (2024) |
| Lundbeck LLC | $671.84 | 35 | $0 (2024) |
| ABBVIE INC. | $464.29 | 29 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $382.23 | 18 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $382.16 | 19 | $0 (2024) |
| Alkermes, Inc. | $373.98 | 8 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $366.86 | 8 | $0 (2024) |
| ITI, Inc. | $197.94 | 9 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $197.46 | 9 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $131.70 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,912 | 100 | Lundbeck LLC ($381.87) |
| 2023 | $1,515 | 89 | ABBVIE INC. ($298.41) |
| 2022 | $752.59 | 14 | Janssen Pharmaceuticals, Inc ($264.61) |
| 2021 | $371.24 | 17 | Sunovion Pharmaceuticals Inc. ($176.73) |
All Payment Transactions
220 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $34.26 | General |
| Category: Neuropsychiatry | ||||||
| 12/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.42 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: ANTI-ANXIETY | ||||||
| 12/11/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: CNS | ||||||
| 12/04/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.75 | General |
| Category: PSYCHIATRY | ||||||
| 11/27/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Neuropsychiatry | ||||||
| 11/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $32.11 | General |
| Category: Neuropsychiatry | ||||||
| 11/20/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.03 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Neuroscience | ||||||
| 10/31/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: ADHD | ||||||
| 10/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Neuropsychiatry | ||||||
| 10/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $32.70 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.22 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $28.34 | General |
| Category: Neuropsychiatry | ||||||
| 10/09/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $8.59 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.25 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $25.85 | General |
| 09/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Neuropsychiatry | ||||||
| 09/18/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Neurology | ||||||
| 09/10/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: ANTI-ANXIETY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 50 | 160 | $34,350 | $9,433 |
| 2022 | 3 | 58 | 118 | $26,405 | $7,695 |
| 2021 | 3 | 59 | 109 | $22,325 | $8,576 |
Total Patients
167
Total Services
387
Medicare Billing
$25,704
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 113 | $22,600 | $5,554 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 47 | $11,750 | $3,879 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 75 | $13,700 | $3,871 | 28.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 23 | $5,655 | $1,963 | 34.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 20 | 20 | $7,050 | $1,861 | 26.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 29 | 30 | $11,200 | $3,689 | 32.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 56 | $7,560 | $3,048 | 40.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 23 | $3,565 | $1,840 | 51.6% |
About Deep Patel
Deep Patel is a Psychiatric/Mental Health healthcare provider based in Riverside, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2017. The National Provider Identifier (NPI) number assigned to this provider is 1194247072.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Deep Patel has received a total of $4,551 in payments from pharmaceutical and medical device companies, with $1,912 received in 2024. These payments were reported across 220 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($4,524).
As a Medicare-enrolled provider, Patel has provided services to 167 Medicare beneficiaries, totaling 387 services with total Medicare billing of $25,704. Data is available for 3 years (2021–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Location Riverside, CA
- Active Since 07/12/2017
- Last Updated 01/10/2020
- Taxonomy Code 363LP0808X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1194247072
Products in Payments
- REXULTI (Drug) $1,213
- VRAYLAR (Drug) $464.29
- INGREZZA (Drug) $382.16
- INVEGA SUSTENNA (Drug) $281.52
- CAPLYTA (Drug) $270.22
- LYBALVI (Drug) $220.20
- LATUDA (Drug) $197.46
- UZEDY (Drug) $146.02
- AUSTEDO (Drug) $144.52
- SPRAVATO (Drug) $109.92
- ABILIFY MAINTENA (Drug) $109.16
- Austedo XR (Drug) $91.69
- TRINTELLIX (Drug) $91.34
- Azstarys (Drug) $90.53
- ARISTADA (Drug) $76.33
- QELBREE (Drug) $69.86
- HETLIOZ (Drug) $65.40
- Qelbree (Drug) $61.84
- Dyanavel XR (Drug) $57.78
- ABILIFY ASIMTUFII (Drug) $52.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Riverside
Mr. Samuel Kaufman, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $17,573
Psychiatric/Mental Health $17,573
Quiana Cooper, Np, NP
Psychiatric/Mental Health — Payments: $4,889
Psychiatric/Mental Health $4,889
Ms. Britni Turano, Ms Rn Pmhnp-Bc, MS RN PMHNP-BC
Psychiatric/Mental Health — Payments: $4,799
Psychiatric/Mental Health $4,799
Mr. Sukh Dev Singh Khalsa, P.m.h.n.p, P.M.H.N.P
Psychiatric/Mental Health — Payments: $3,033
Psychiatric/Mental Health $3,033
Racheal Aneke
Psychiatric/Mental Health — Payments: $2,315
Psychiatric/Mental Health $2,315
Jessica Millan, Np, NP
Psychiatric/Mental Health — Payments: $2,235
Psychiatric/Mental Health $2,235